Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: A pilot study

Journal of the Society for Gynecologic Investigation

Volumn 11, Issue 4, 2004, Pages 227-231

  Tempfer, Clemens B ^a   Jirecek, Stefan ^b   Riener, Eva Katrin ^b   Zeisler, Harald ^b   Denschlag, Dominik ^b   Hefler, Lukas ^b   Husslein, Peter W ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE

Author keywords

gene; multigenetic model; polymorphism; Preeclampsia; risk

Indexed keywords

ANGIOTENSINOGEN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5; CORTICOSTEROID RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR ALPHA; MINERALOCORTICOID RECEPTOR; OLIGONUCLEOTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; VASOACTIVE AGENT;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA MICROARRAY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; RISK FACTOR; SOLID;

ADULT; ANGIOTENSINOGEN; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD VESSELS; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PILOT PROJECTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PROTHROMBIN; RECEPTORS, MINERALOCORTICOID;

EID: 2342428666     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsgi.2003.12.002     Document Type: Article

References (23)

1. Shastry B.S. SNP alleles in human disease and evolution. J Hum Genet. 47:2002;561-566
2. Evans W.E., McLeod H.L. Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med. 348:2003;538-549
3. Khoury M.J., McCabe L.L., McCabe E.R. Population screening in the age of genomic medicine. N Engl J Med. 348:2003;50-58
4. Li W.H., Gu Z., Wang H., Nekrutenko A. Evolutionary analyses of the human genome. Nature. 409:2001;847-849
5. Rey E., Kahn S.R., David M., Shrier L. Thrombophilic disorders and fetal loss A meta-analysis. Lancet. 361:(9361):2003;901-908
6. Adelberg A.M., Kuller J.A. Thrombophilias and recurrent miscarriage. Obstet Gynecol Surv. 57:(10):2002;703-709
7. Glueck C.J., Kupferminc M.J., Fontaine R.N., Wang P., Weksler B.B., Eldor A. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol. 97:(1):2001;44-48
8. Zhang X.Q., Varner M., Dizon-Townson D., Song F., Ward K. A molecular variant of angiotensinogen is associated with intrauterine growth restriction. Obstet Gynecol. 101:(2):2003;237-242
9. Tempfer C.B., Dorman K., Deter R.I., O'Brien W.E., Gregg A.R. An endothelial nitric oxide synthase gene polymorphism is associated with preeclampsia. Hypertens Pregnancy. 20:(1):2001;107-118
10. Morrison E.R., Miedzybrodzka Z.H., Campbell D.M., et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension Results from a large population-based study and systematic review. Thromb Haemost. 87:(5):2002;779-785
11. Infante-Rivard C., Rivard G.E., Yotov W.V., et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med. 347:(1):2002;19-25
12. Endler G., Mannhalter C. Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta. 330:(1-2):2003;31-55
13. Chesley L.C., Cosgrove R.A., Annito J.E. Pregnancy in the sisters and daughters of eclamptic women. Path Microbiol. 24:1961;662-666
14. Dawson L.M., Parfrey P.S., Hefferton D., et al. Familial risk of preeclampsia in Newfoundland A population-based study. J Am Soc Nephrol. 13:(7):2002;1901-1906
15. Esplin M.S., Fausett M.B., Fraser A., et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med. 344:(12):2001;867-872
16. American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. ACOG practice bulletin no. 33. Washington DC: American College of Obstetricians and Gynecologists, 2002
17. Huber M., Mundlein A., Dornstauder E., et al. Accessing single nucleotide polymorphisms in genomic DNA by direct multiplex polymerase chain reaction amplification on oligonucleotide microarrays. Anal Biochem. 303:2002;25-33
18. Guo Z., Guilfoyle R.A., Thiel A.J., Wang R., Smith L.M. Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports. Nucleic Acids Res. 22:1994;5456-5465
19. Wallace R.B., Shaffer J., Murphy R.F., Bonner J., Hirose T., Itakura K. Hybridization of synthetic oligodeoxyribonucleotides to phi chi 174 DNA The effect of single base pair mismatch. Nucleic Acids Res. 6:1979;3543-3557
20. Baudin B. Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations. Pharmacogenomics. 3:(1):2002;65-73
21. Geller D.S. A mineralocorticoid receptor mutation causing human hypertension. Curr Opin Nephrol Hypertens. 10:(5):2001;661-665
22. Benedetto C., Marozio L., Salton L., Maula V., Chieppa G., Massobrio M. Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome. Acta Obstet Gynecol Scand. 81:(12):2002;1095-1100
23. Kobashi G., Yamada H., Ohta K., Kato E., Ebina Y., Fujimoto S. Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy. Am J Med Genet. 103:(3):2001;241-244